Judge Nixes Infosint's $15M Patent Win Over Citalopram

Law360 (June 17, 2010, 7:19 PM EDT) -- A federal judge ruled Thursday that an Infosint SA patent related to the manufacture of antidepressant citalopram was invalid, throwing out an earlier $15 million infringement verdict against defendants H. Lundbeck A/S and Forest Laboratories Inc.

Judge Lewis Kaplan of the U.S. District Court for the Southern District of New York granted the defendants judgment as a matter of law, finding Infosint's patent for the synthesis of a chemical compound used in making citalopram invalid due to obviousness.

The judge also denied a defense motion to reconsider a finding of infringement as moot and threw out a motion by Infosint to...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!